Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for G5EG51

Entry ID Method Resolution Chain Position Source
AF-G5EG51-F1 Predicted AlphaFoldDB

No variants for G5EG51

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for G5EG51

No associated diseases with G5EG51

No regional properties for G5EG51

Type Name Position InterPro Accession
No domain, repeats, and functional sites for G5EG51

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Nucleus speckle
  • Nucleus, nucleolus
  • Accumulation of siRNAs promotes translocation of the protein to the nucleolus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

4 GO annotations of biological process

Name Definition
gene silencing by RNA A process in which an RNA molecule reduces expression of target genes. This can occur pre-transcriptionally by assembly of heterochromatin and prevention of transcription or co- or post-transcriptionally by targeting RNAs for degradation or by interfering with splicing or translation. This process starts once the inhibitory RNA molecule has been transcribed, and includes processing of the RNA such as cleavage, modifications, transport from the nucleus to the cytoplasm, loading onto the RISC complex, and the effect on transcription or translation.
heterochromatin assembly by small RNA A heterochromatin formation-based gene silencing process mediated by a small RNA molecule that occur before the beginnning of trancription.
negative regulation of RNA catabolic process Any process that stops, prevents or reduces the frequency, rate or extent of RNA catabolic process.
post-transcriptional gene silencing by RNA A posttranscriptional gene silencing pathway in which regulatory RNAs elicit silencing of specific target genes, either by mRNA destabilization or inhibition of translation.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9H7Z3 NRDE2 Nuclear exosome regulator NRDE2 Homo sapiens (Human) PR
Q80XC6 Nrde2 Nuclear exosome regulator NRDE2 Mus musculus (Mouse) PR
10 20 30 40 50 60
MFRAYGNNGL KNPERISGEN PDLYTQTRAA VQQRATTTLK RNEKQKLAVQ NDSVFQQVGI
70 80 90 100 110 120
GESDSDDDNG GVRIRMSPHR YIDPDDVFTL PEVKKQNALR DAKIAARAAQ ATAYNTFPSV
130 140 150 160 170 180
KSLNGCQDPP ETSQQSTSRK RSASNSRSPS RSHSRRYDRD NGRQRSRSRE KKRRKKERRR
190 200 210 220 230 240
KRSSSRSSSS SRSRDRSSRA RDTSSHTLMK MNKPAKYAFL TDEEYRTCDA YISSAFITQT
250 260 270 280 290 300
KSDCENYTQG VPKKEIAKCR LSVKFIVGLE HNNILFNNIY GAEYARDKEN RPFWEQLDRY
310 320 330 340 350 360
LKDVPKETFF RYVPPVGGYW KIRDRVDLLN LDHIDDDVLA NDSDNRKDAF TFELEQAKKT
370 380 390 400 410 420
FSENVHNIDA LIKVISMEEE MCRRNVGSFS SSNPAALAER HQEMVKKAIK ADGRNAKLRL
430 440 450 460 470 480
MKIELLIKMD PNSPTIIDDF KNLTITFPHE PMVWIKYLDY IQYDSNVYNY KKLKNAFEDC
490 500 510 520 530 540
IRQVTGLTNG TLLSHLNAVN DRPLLRMFHL WIYIRYLKWM ISCAHTPVVL ANIQATFEYN
550 560 570 580 590 600
FGLADVEKRT STNSKEREVR LEEFWESGLP RIGDEGAVGA EKMLKQSEEL SDEDIQKLEN
610 620 630 640 650 660
DDFDILISRT EETIATCLQA QRDVQISWIE VEREMMNIDA RVKRTKLKDC ELYEDHVDDL
670 680 690 700 710 720
ETCELWDIIP FDRIRYYEAP GDCANFDFVQ PFLELLGVKF LNSTNCFTTT EQIISDWISN
730 740 750 760 770 780
DSTVNFYKTP TYTEKKCFEV GNNILKFMLY NRLKLTENNP EYLDKTMVKY LLAMLVTEAS
790 800 810 820 830 840
EQEKKLNFHS FKLNLKNLVG TFITKHPDIF KRAMLSKITG IVYMEKFVSW WERALKEQEK
850 860 870 880 890 900
VVEADERRKN YKEIKMEEGV VDDVKFDVIL LKKDKERVQT IRDKIRDMID IAIPKSTEKL
910 920 930 940 950 960
IQSADSSLPT LQLHLYANVL RGRLSILNQN ALEETRDVFC KEILGIHTSE FESDEALLLA
970 980 990 1000 1010 1020
LDQGLNELLE HCKEKDNLES VDSIPELPRA EALCEALKVV AVFVFLDKMA FSRRAVDCLI
1030 1040 1050 1060 1070 1080
ANAITKFEQF EAKKNDFNRG TYEKYCDQID LKFITDTLIT FFSHKKHRFI YNENFKKLIF
1090 1100 1110 1120 1130 1140
QASQAFPCDS KYAKMLGELH SSGRLQVMKL QGFTDSRNSI LNAKRDQQFD PELETRLLMN
1150 1160 1170 1180 1190 1200
SLTIMFSWMN AANRIGDAGN QILYKNWKRE AANTRDPAIW RQVIRVASKL SQKILKDDAY
1210 1220 1230 1240 1250 1260
TRARGQCTWA LNLHFDYIEA KTVRKNGDLM EMIYLILEQS MGQEHSLFVT DEEYMKTQQE
IGLQYSESGR